Published on: July 27, 2020 |
By: Todd Mitchell
The market showed strength throughout Monday’s session as progress on the next stimulus bill and perhaps some bargain hunting after last weeks’ declines fueled gains. Continued good news on a possible vaccine development was also in focus after Moderna (MRNA) said it has begun Phase 3 trials, with results expected by November. The Nasdaq....
Continue Reading